Skip to main content
Clinical Trials/IRCT20180430039488N1
IRCT20180430039488N1
Recruiting
Phase 3

Evaluation of the efficacy of high dose corticosteroid regimen for treatment of postoperative high degree Atrioventricular block after valvular cardiac surgery ; A single blind randomized clinical trial

Tehran Heart Center0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Advanced atrioventricular block following heart valve surgery.
Sponsor
Tehran Heart Center
Enrollment
150
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tehran Heart Center

Eligibility Criteria

Inclusion Criteria

  • Presence of advanced atrioventricular block following heart valve surgery including valve replacement or repair with or without CABG
  • Written documented informed consent

Exclusion Criteria

  • Exclusion of patients having cardiac pacemakers or intracardiac defibrilator\-cardiovertor or CRT
  • Exclusion of subjects having prior advanced AV block with underlying congenital or acquired etiologies or known brady\-arrhythmia
  • Exclusion of patients with acute or recent myocardial infarction or CPR during last week (or survivors of aborted sudden cardiac death)
  • Exclusion of diabetics with uncontrolled hyperglycemia ( BS\>200 in 2 or more measurements out of 4 samples during last 24 hours or HbA1C\>9, ketoacidosis or hyperglycemic hyperosmolar state)
  • Exclusion of patients with active infections
  • Exclusion of patients with immune deficiency disorders including malignancies and HIV\-AIDS,....
  • Exclusion of patients with prior history of hypersensitivity reactions to steroids
  • Exclusion of patients with persistent or permanent atrial fibrillation (AF for more than 24 hours except transient or paroxysmal cases)

Outcomes

Primary Outcomes

Not specified

Similar Trials